Edition:
India

Mangalam Drugs and Organics Ltd (MADR.NS)

MADR.NS on National Stock Exchange of India

145.95INR
19 Oct 2017
Change (% chg)

Rs0.10 (+0.07%)
Prev Close
Rs145.85
Open
Rs147.70
Day's High
Rs147.70
Day's Low
Rs145.10
Volume
14,190
Avg. Vol
65,553
52-wk High
Rs214.90
52-wk Low
Rs122.60

Chart for

About

Mangalam Drugs and Organics Limited is an India-based company, which is engaged in the manufacture of drugs, medicines and allied products. The Company's geographical segments include Domestic and Export. It also manufactures active pharmaceutical ingredients (APIs), intermediates and specialty chemicals. Its API products... (more)

Overall

Beta: 0.18
Market Cap(Mil.): Rs2,370.28
Shares Outstanding(Mil.): 15.83
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 30.44 16.24
EPS (TTM): -- -- --
ROI: -- 14.17 10.90
ROE: -- 15.52 14.09

BRIEF-India's Mangalam Drugs & Organics gets final nod from WHO for emtricitabine

* Says received final approval from WHO for drug emtricitabine Source text - http://bit.ly/2h7s5rB Further company coverage:

15 Sep 2017

BRIEF-India's Mangalam Drugs and Organics June-qtr profit falls

* June quarter net profit after tax 41.6 million versus profit 45.6 million rupees year ago

11 Aug 2017

BRIEF-Mangalam Drugs and Organics gets final approval of WHO-Geneva for unit-2 at Vapi

* Says got final approval of WHO-Geneva for its plant on unit-2 at Vapi Source text for Eikon: Further company coverage:

25 May 2017

BRIEF-India's Mangalam Drugs and Organics March-qtr profit rises

* March quarter net profit 65.6 million rupees versus profit 55.3 million rupees year ago

08 May 2017

Earnings vs. Estimates